IL145025A0 - Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses - Google Patents

Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses

Info

Publication number
IL145025A0
IL145025A0 IL14502500A IL14502500A IL145025A0 IL 145025 A0 IL145025 A0 IL 145025A0 IL 14502500 A IL14502500 A IL 14502500A IL 14502500 A IL14502500 A IL 14502500A IL 145025 A0 IL145025 A0 IL 145025A0
Authority
IL
Israel
Prior art keywords
epsilon
ige
epitopes
antagonists
domains
Prior art date
Application number
IL14502500A
Original Assignee
Smithkline Beecham Biolog
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9904408.3A external-priority patent/GB9904408D0/en
Priority claimed from GBGB9917144.9A external-priority patent/GB9917144D0/en
Priority claimed from GBGB9918601.7A external-priority patent/GB9918601D0/en
Priority claimed from GBGB9918598.5A external-priority patent/GB9918598D0/en
Priority claimed from GBGB9918604.1A external-priority patent/GB9918604D0/en
Priority claimed from GBGB9918606.6A external-priority patent/GB9918606D0/en
Priority claimed from GBGB9918599.3A external-priority patent/GB9918599D0/en
Priority claimed from GBGB9925618.2A external-priority patent/GB9925618D0/en
Application filed by Smithkline Beecham Biolog, Peptide Therapeutics Ltd filed Critical Smithkline Beecham Biolog
Publication of IL145025A0 publication Critical patent/IL145025A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
IL14502500A 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses IL145025A0 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9904408.3A GB9904408D0 (en) 1999-02-25 1999-02-25 Vaccine
GBGB9917144.9A GB9917144D0 (en) 1999-07-21 1999-07-21 Vaccine
GBGB9918601.7A GB9918601D0 (en) 1999-08-07 1999-08-07 Novel peptides
GBGB9918598.5A GB9918598D0 (en) 1999-08-07 1999-08-07 Novel peptides
GBGB9918604.1A GB9918604D0 (en) 1999-08-07 1999-08-07 Novel peptides
GBGB9918606.6A GB9918606D0 (en) 1999-08-07 1999-08-07 Novel peptides
GBGB9918599.3A GB9918599D0 (en) 1999-08-07 1999-08-07 Novel peptides
GBGB9925618.2A GB9925618D0 (en) 1999-10-29 1999-10-29 Vaccine
PCT/EP2000/001456 WO2000050461A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses

Publications (1)

Publication Number Publication Date
IL145025A0 true IL145025A0 (en) 2002-06-30

Family

ID=27571340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14502500A IL145025A0 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses

Country Status (18)

Country Link
EP (1) EP1155038A1 (en)
JP (1) JP2002537403A (en)
KR (1) KR20020007314A (en)
CN (1) CN1520423A (en)
AR (1) AR029619A1 (en)
AU (1) AU3281100A (en)
CA (1) CA2363641A1 (en)
CO (1) CO5231139A1 (en)
CZ (1) CZ20013081A3 (en)
HK (1) HK1043134A1 (en)
HU (1) HUP0105490A3 (en)
IL (1) IL145025A0 (en)
MX (1) MXPA01008612A (en)
NO (1) NO20014131L (en)
NZ (1) NZ513680A (en)
PL (1) PL350992A1 (en)
TR (1) TR200102493T2 (en)
WO (1) WO2000050461A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2206701A (en) * 1999-12-21 2001-07-03 Acambis Research Limited A reversible linkage technology for controlled conjugation
WO2001085208A2 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
GB0026334D0 (en) * 2000-10-27 2000-12-13 Smithkline Beecham Biolog Vaccine
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
JP2003047482A (en) * 2001-05-22 2003-02-18 Pfizer Prod Inc IgE VACCINE FREE FROM ANAPHYLAXIS-INDUCING PROPERTY
CN1599623B (en) 2001-09-14 2011-05-11 赛托斯生物技术公司 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
GB0209878D0 (en) * 2002-04-30 2002-06-05 Glaxosmithkline Biolog Sa Vaccine
WO2004007538A2 (en) 2002-07-17 2004-01-22 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
CN101574518B (en) 2002-07-18 2012-08-22 赛托斯生物技术公司 Hapten-carrier conjugates and uses thereof
DK1524994T3 (en) 2002-07-19 2011-08-15 Cytos Biotechnology Ag Vaccine compositions containing amyloid beta 1-6 antigen arrays
US7537767B2 (en) 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
CN100560719C (en) 2003-03-26 2009-11-18 赛托斯生物技术公司 The MELAN-A peptide analogue-virus-like-particle conjugates
AU2004315197B2 (en) * 2004-02-02 2009-06-04 Tanox, Inc. Identification of novel IgE epitopes
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
EP1941275B1 (en) 2005-09-29 2013-07-24 Medimmune, Inc. Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
JP5484732B2 (en) 2005-12-14 2014-05-07 サイトス バイオテクノロジー アーゲー Immunostimulatory nucleic acid package particles for the treatment of hypersensitivity
NZ573622A (en) 2006-06-12 2011-12-22 Cytos Biotechnology Ag Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
ES2622562T3 (en) 2008-12-09 2017-07-06 Pfizer Vaccines Llc IgE CH3 peptide vaccine
EP2575868A1 (en) 2010-06-07 2013-04-10 Pfizer Vaccines LLC Ige ch3 peptide vaccine
WO2013191166A1 (en) * 2012-06-18 2013-12-27 日本全薬工業株式会社 IgE PEPTIDE VACCINE
US20210055305A1 (en) * 2018-04-06 2021-02-25 Slsbio Co., Ltd. Novel epitope of immunoglobulin e, antibody binding thereto, and kit for analyzing immunoglobulin e in sample containing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02229200A (en) * 1989-02-28 1990-09-11 Dainippon Pharmaceut Co Ltd Peptide having anti-allergic activity
DK0602126T3 (en) * 1991-08-14 2003-06-16 Genentech Inc Immunoglobulin variants for specific FC epsilon receptors
AU719609B2 (en) * 1996-03-01 2000-05-11 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
AU6532498A (en) * 1996-12-06 1998-06-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Inhibition of ige-mediated allergies by a human ige-derived oligopeptide
TWI227241B (en) * 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate

Also Published As

Publication number Publication date
MXPA01008612A (en) 2003-06-24
AR029619A1 (en) 2003-07-10
HUP0105490A2 (en) 2002-04-29
PL350992A1 (en) 2003-02-24
NO20014131L (en) 2001-10-02
CO5231139A1 (en) 2002-12-27
JP2002537403A (en) 2002-11-05
NO20014131D0 (en) 2001-08-24
CA2363641A1 (en) 2000-08-31
EP1155038A1 (en) 2001-11-21
KR20020007314A (en) 2002-01-26
AU3281100A (en) 2000-09-14
NZ513680A (en) 2001-09-28
WO2000050461A1 (en) 2000-08-31
CZ20013081A3 (en) 2002-02-13
TR200102493T2 (en) 2002-02-21
HUP0105490A3 (en) 2002-05-28
HK1043134A1 (en) 2002-09-06
CN1520423A (en) 2004-08-11

Similar Documents

Publication Publication Date Title
PL350992A1 (en) Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
GB9927056D0 (en) Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
AU8729101A (en) Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for the treatment of B cell lymphoma
IL144147A0 (en) Regulators of the pct or smoothened pathway, compositions and uses related thereto
IS5113A (en) Use of CB1 antagonists for the treatment of craving disorders
DE69836514D1 (en) Electrode body, provided with this accumulator, and production of the electrode body and the accumulator
IL154272A0 (en) The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
ZA200401214B (en) Synthesis of poly-alpha olefin and use thereof.
HUP9900163A2 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
PL356848A1 (en) Novel imidazo[1,3,5]triazinones and the use thereof
WO1999029729A3 (en) Antagonists of neuropilin receptor function and use thereof
ID30116A (en) PIRIDOPIRANOAZEPIN DECREASES, THE PRODUCTION AND USE OF THERAPY
ID19245A (en) VITRONEKTIN RECEPTOR ANTAGONISTS, THE PRODUCTION AND USE OF IT
HK1043059A1 (en) Tumor necrosis factor antagonists and their use inendometriosis.
IL144776A0 (en) Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
ZA200204635B (en) Fragments and antagonists of heat shock protein 60.
TW382921U (en) Structure of improved model for the umbrella
IL145024A0 (en) Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
PL338453A1 (en) 2-acylaminopropanoamines as antagonists of the tachykinin receptor
ZA200403530B (en) Chemokine receptor antagonists and methods of use thereof.
ZA200107015B (en) Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses.
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
PL338456A1 (en) 2-acylaminopropanoamines as antagonists of the tachykinin receptor
EP1433849A4 (en) Novel polypeptide, dna thereof and use of the same